PENCLONAC

This brand name is authorized in Nigeria.

Active ingredients

The drug PENCLONAC contains one active pharmaceutical ingredient (API):

1	Aceclofenac UNII RPK779R03H - ACECLOFENAC
	Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins.
	Read more about Aceclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4453	Tablet	Penclonac 100 Tablet TAB 100 mg 110	Penclonac 100 Tablet Aceclofenac 100 Tablet Aceclofenac 100mg, Microcrystalline cellulose 225mg, Lactose monohydrate 20mg, Colloidal anhydrous silica 7.5mg, Croscarmellose sodium 10mg, Magnesium stearate 7.5mg, Tabcoat light pink 15mg, B4-4453 Drugs Imported Products 110 Prescription Only Medicine (POM) 22/09/2020 ASPEN PHARMACARE NIGERIA LIMITED, plot 28,infinty house,ilupeju bypass 9062496814 dadeduro@ng.aspenpharma.com SHELYS PHARMACEUTICALS LTD, PLOT NO 696, NEW BAGAMOYO ROAD, MWENGE, P.O. BOX 32781, DAR ES SALAAM, TANZANIA, Tanzania	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB16	Aceclofenac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4453